Literature DB >> 3497948

Acute hematogenous osteomyelitis in children.

R L LaMont, P A Anderson, A S Dajani, M C Thirumoorthi.   

Abstract

Sixty-nine children with acute hematogenous osteomyelitis were studied retrospectively. All were treated with antibiotics, and eight underwent fenestration osteotomies. In the operatively treated group, three poor results occurred. In a more recent prospective study of 44 patients, drainage was undertaken only when pus was aspirated. All results were good or excellent. We recommend operative drainage only when a demonstrated abscess is found by aspiration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497948     DOI: 10.1097/01241398-198709000-00015

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  6 in total

Review 1.  Acute hematogenous osteomyelitis in children: recognition and management.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 2.  Pediatric emergencies.

Authors:  J S Surpure
Journal:  Indian J Pediatr       Date:  1988 May-Jun       Impact factor: 1.967

3.  Two decades of acute hematogenous osteomyelitis in children: are there any changes?

Authors:  D Malcius; G Trumpulyte; V Barauskas; A Kilda
Journal:  Pediatr Surg Int       Date:  2005-04-15       Impact factor: 1.827

Review 4.  Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery.

Authors:  Kenneth L Urish; James E Cassat
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

5.  Complications of suppurative arthritis and osteomyelitis in children.

Authors:  S Porat; K Goitien; B S Saperia; M Liebergall; K Abu-Dalu; S Katz
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

Review 6.  Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review.

Authors:  Nicole Le Saux; Andrew Howard; Nicholas J Barrowman; Isabelle Gaboury; Margaret Sampson; David Moher
Journal:  BMC Infect Dis       Date:  2002-08-14       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.